TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Tectonic Therapeutic, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$21.15+0.50 (+2.42%)
Close on Oct 19, 2026
- Market cap
- $401.09M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Margins need revenue and profit figures
This company does not report the lines needed to calculate margins.
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -54.4% | -37.8% | |
| Return on assets | – | -50.8% | -35.8% | |
| Current ratio | – | 16.09 | 26.63 | |
| Debt to equity | – | – | – | |
| Net debt to EBITDA | – | – | – | |
| Interest coverage | – | – | -1333.9× | |
| Diluted shares | – | 1M | 18M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Tectonic Therapeutic generated $355.07M from operations and spent $3.37M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$355.07M
Used
$3.37M
Capital expenditure$3.37M100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 6 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$74.15M
- Cash generatingOperating cash flow above zero-$60.08M
- Return on assets improvedROA up on the prior year-147.2% → -48.5%
- Earnings backed by cashOperating cash flow above net income-$60.08M vs -$74.15M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose12.65 → 26.63
- No dilutionShare count did not rise8M → 18M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –